Cellebrite DI Ltd. Hits New 52-Week Low at USD 11.76

Cellebrite DI Ltd., a small-cap player in the software products industry, has recently reached a new 52-week low of USD 11.76 on February 23, 2026. This decline marks a significant downturn for the company, especially when compared to its 52-week high of USD 20.86. Over the past year, Cellebrite DI has recorded a performance of 2.31%, which contrasts sharply with the S&P 500's performance of 12.95%. The company's market capitalization stands at USD 3,152 million, reflecting its position within the small-cap segment. Financial metrics indicate that Cellebrite DI is currently loss-making, as evidenced by the absence of a price-to-earnings (P/E) ratio. The company also has a negative debt-to-equity ratio of -0.89, suggesting a unique financial structure. Despite these challenges, Cellebrite DI boasts a return on equity of 16.87% and a price-to-book ratio of 6.51. As the stock navigates this low point, it highlights the ongoing dynamics within the software products sector and the company's current market standing.